DT Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6K Hold
62
﹤0.01% 287
2026
Q1
$34.8K Hold
62
﹤0.01% 271
2025
Q4
$41.9K Hold
62
﹤0.01% 264
2025
Q3
$39.6K Hold
62
﹤0.01% 260
2025
Q2
$33.3K Hold
62
﹤0.01% 273
2025
Q1
$26K Hold
62
﹤0.01% 293
2024
Q4
$25.6K Sell
62
-65
-51% -$28.5K ﹤0.01% 297
2024
Q3
$64.2K Sell
127
-10
-7% -$4.86K 0.01% 228
2024
Q2
$66.7K Buy
137
+75
+121% +$37.7K 0.01% 215
2024
Q1
$33.5K Hold
62
﹤0.01% 249
2023
Q4
$32.3K Hold
62
﹤0.01% 247
2023
Q3
$27.1K Hold
62
﹤0.01% 238
2023
Q2
$33K Hold
62
﹤0.01% 232
2023
Q1
$30.4K Hold
62
﹤0.01% 232
2022
Q4
$25.3K Hold
62
﹤0.01% 245
2022
Q3
$20K Buy
+62
New +$22.8K ﹤0.01% 251

Other funds holding IDXX

DT Investment Partners's IDXX Position: Q2 2026 in Review

DT Investment Partners held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 62 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

DT Investment Partners first reported a position in IDXX in Q3 2022 and has held it in 16 quarters since. The position peaked at $66.7K in Q2 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • DT Investment Partners held 62 shares of Idexx Laboratories worth $32.6K as of Q2 2026.
  • DT Investment Partners left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #287 holding.
  • DT Investment Partners first reported a position in Idexx Laboratories in Q3 2022 and has held it in 16 quarters since.
  • DT Investment Partners's Idexx Laboratories position peaked at $66.7K in Q2 2024.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.